Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

French CTA boutique launches UCITS version of flagship fund

Thursday, July 14, 2011

Francois Bonnin
Opalesque Industry Update - French fund management boutique John Locke Investments launched a UCITS compliant version of its flagship fund, the Cyril Systematic USD Fund, on 1st July. The UCITS fund replaces an onshore version of Cyril Systematic that previously existed.

The new UCITS structure will allow the firm to distribute its fund abroad more easily than the previous onshore structure. And the strategy will remain exactly the same as the original version.

The Cyril Systematic USD Fund, launched exactly 11 years ago, manages around $17m, according to John Lockes website. It invests in global futures markets with a systematic trading approach, using multiple trend detection techniques over multiple time horizons. Risk is equalised across all contracts through the use of real time volatility measures. And average holding periods last approximately two weeks.

The fund was fund down 3.26% in June and down 9.61% YTD (annualizing almost 8% with around 13% volatility). Most loses in June occurred in the energy sector, especially in the Brent Crude, natgas and gas oil markets. Also in metals, equity indices, and grains. Gains were made in bond and short term rates trading.

Comparatively, the Barclay CTA Index was down 1.27% (est.) in June (-1.47% YTD). Also the UCITS Alternative CTA Index returned -0.93% in June (-2.43% YTD).

John Locke Investments (JLI) is an independent alternative asset management company based in Fontainebleau, France. JLI is regulated by the A.M.F (Autorit des Marchs Financiers), is registered with the Commodity Futures Trading Commission (CFTC) as a Commodity Trading Advisor (CTA) and as a Commodity Pool Operator (CPO) and is a member of the National Futures Association (NFA).

B. Gravrand


See last years Opalesque TV interview of Francois Bonnin, CEO and hedge fund manager at John Locke: Part 1, Part 2.

And the corresponding articles:
Opalesque Exclusive: John Locke's CEO Bonnin (1): How he discovered the world of quant and why the French like it so Source
Opalesque Exclusive: John Locke's CEO Bonnin (2): Stepping up from trend following to Machine Learning, Chains of Markov, Support Vector Machines and Kelly Rule Source

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for